Cambridge Capital Group
Funding rounds backed by Cambridge Capital Group.
- Funding disclosed in full
- $3.8M
- Median round
- $3.8M
- Rounds in calculation
- 1
| Company | Round | Market | Investors | Announced | Details |
|---|---|---|---|---|---|
| Semarion Develops next-generation cell assay technology for drug discovery | $3.8MUndisclosed | BiotechUnited Kingdom |